Commercialisation

DMTC Intellectual Property is identified as it is created in projects and captured and protected to deliver maximum value to DMTC and Defence. DMTC owns all IP but makes it available to Partner organisations through a unique automatic licensing model that was developed during the initiation of the DMTC.

The most common pathway for commercialisation will be through licence agreements with end-users who are either direct or indirect suppliers to Defence and, in most cases, are DMTC participant organisations. While Defence is the primary end-user of research projects undertaken by DMTC, opportunities will exist for dual-use adaptation to commercial applications in industries such as civilian aviation, marine, medicine, automotive and power generation. For strategic and national security reasons, a small number of technologies will not be available for commercialisation. Any net returns from commercialisation will be re-invested into further R&D to be undertaken by DMTC’s partner organisations.